We are live on
!
Find out more
CFG
Cambridge Financial Group Portfolio holdings
AUM
$267M
1-Year Est. Return
31.62%
This Fund
S&P 500
This Quarter
Est. Return
-0.82%
1 Year Est. Return
+31.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$189M
Cap. Flow
% of AUM
103.22%
Top 10 Holdings %
Top 10 Hldgs %
40.01%
Holding
32
New
32
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$8.26M |
| 2 |
Cardinal Health
CAH
|
+$7.74M |
| 3 |
Linde
LIN
|
+$7.69M |
| 4 |
Broadcom
AVGO
|
+$7.64M |
| 5 |
Ryder
R
|
+$7.45M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.41% |
| 2 | Healthcare | 16.38% |
| 3 | Energy | 13.87% |
| 4 | Financials | 13.18% |
| 5 | Industrials | 11.31% |
Similar funds
EU
PC
ALC
TWM
IP
SP
EAIC
TGI
Cambridge Financial Group's Q3 2023 Portfolio in Review
Q3 2023 is the first quarter with a 13F filing on record for Cambridge Financial Group, which disclosed 32 positions worth $184M. Its ten largest holdings account for 40% of the portfolio.
Its largest position is Cencora: 44,731 shares worth $8.05M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, followed by Healthcare and Energy.
- Cambridge Financial Group's largest Q3 2023 buy was Cencora: 44,731 shares worth $8.05M.
- Cambridge Financial Group's ten largest holdings make up 40% of its $184M portfolio in Q3 2023.
- Cambridge Financial Group disclosed 32 positions in Q3 2023, its first 13F filing on record.
Based on Cambridge Financial Group's 13F filing for Q3 2023, filed 13 Nov 2023.